Cardiff Lexington Corp (CDIX) stock
CDIXOTCServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
$0.04−0.01 (-25.53%)
Close on Oct 19, 2026Market cap $550.31KP/E –Yield –
Cardiff Lexington ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cardiff Lexington's ebitda for the twelve months ending Sep 30, 2026 was -$2.29M, down 207.0% year over year. For fiscal 2025 it was $1.11M. The highest annual figure on record is $5.22M in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11M | – |
| FY2024 | Dec 31, 2024 | -$180.04K | -103.5% |
| FY2023 | Dec 31, 2023 | $5.22M | +32.7% |
| FY2022 | Dec 31, 2022 | $3.93M | +134.5% |
| FY2021 | Dec 31, 2021 | $1.68M | – |
| FY2020 | Dec 31, 2020 | -$1.78M | – |
| FY2019 | Dec 31, 2019 | -$1.20M | – |
| FY2018 | Dec 31, 2018 | -$1.94M | – |
| FY2017 | Dec 31, 2017 | -$2.76M | – |
| FY2016 | Dec 31, 2016 | -$1.99M | – |
| FY2015 | Dec 31, 2015 | -$3.83M | – |
| FY2014 | Dec 31, 2014 | -$12.41M | – |
| FY2013 | Dec 31, 2013 | -$11.04M | – |
| FY2012 | Dec 31, 2012 | -$803.48K | – |
| FY2011 | Dec 31, 2011 | -$1.08M | – |
| FY2010 | Dec 31, 2010 | -$1.42M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$536.43K | -183.3% |
| Q2 FY2026 | Jun 30, 2026 | -$544.39K | -189.2% |
| Q1 FY2026 | Mar 31, 2026 | -$510.57K | -193.3% |
| Q4 FY2025 | Dec 31, 2025 | -$695.54K | -307.3% |
| Q3 FY2025 | Sep 30, 2025 | $644.04K | – |
| Q2 FY2025 | Jun 30, 2025 | $610.44K | – |
| Q1 FY2025 | Mar 31, 2025 | $547.30K | +146.1% |
| Q4 FY2024 | Dec 31, 2024 | $335.51K | -20.9% |
| Q3 FY2024 | Sep 30, 2024 | -$581.80K | -125.6% |
| Q2 FY2024 | Jun 30, 2024 | -$156.12K | -108.9% |
| Q1 FY2024 | Mar 31, 2024 | $222.36K | -70.8% |
| Q4 FY2023 | Dec 31, 2023 | $424.08K | -26.4% |
| Q3 FY2023 | Sep 30, 2023 | $2.28M | +51.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.75M | +55.3% |
| Q1 FY2023 | Mar 31, 2023 | $762.18K | +4.1% |
| Q4 FY2022 | Dec 31, 2022 | $576.37K | -82.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.50M | +40.1% |
| Q2 FY2022 | Jun 30, 2022 | $1.13M | – |
| Q1 FY2022 | Mar 31, 2022 | $732.30K | – |
| Q4 FY2021 | Dec 31, 2021 | $3.32M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.07M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.36M | – |
| Q1 FY2021 | Mar 31, 2021 | -$370.26K | – |
| Q4 FY2020 | Dec 31, 2020 | -$906.75K | – |
| Q3 FY2020 | Sep 30, 2020 | -$530.25K | -443.4% |
| Q2 FY2020 | Jun 30, 2020 | -$126.52K | – |
| Q1 FY2020 | Mar 31, 2020 | -$218.35K | – |
| Q4 FY2019 | Dec 31, 2019 | -$804.73K | – |
| Q3 FY2019 | Sep 30, 2019 | $154.39K | – |
| Q2 FY2019 | Jun 30, 2019 | -$396.52K | – |
| Q1 FY2019 | Mar 31, 2019 | -$190.25K | – |
| Q4 FY2018 | Dec 31, 2018 | -$317.39K | – |
| Q3 FY2018 | Sep 30, 2018 | -$925.30K | – |
| Q2 FY2018 | Jun 30, 2018 | -$384.97K | – |
| Q1 FY2018 | Mar 31, 2018 | -$368.95K | – |
| Q4 FY2017 | Dec 31, 2017 | -$495.27K | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.28M | – |
| Q2 FY2017 | Jun 30, 2017 | -$633.60K | – |
| Q1 FY2017 | Mar 31, 2017 | -$401.64K | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.09M | – |
See a number that looks wrong?